Project Dulce for Arab Americans With Type 2 Diabetes

Status: Recruiting
Location: See all (2) locations...
Intervention Type: Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Arab Americans (AA) face many challenges in diabetes self-management due to the limited educational resources and support available for them. The cultural and linguistic barriers between patients and health care providers lead to poor diabetes management and outcomes. This study (Project Dulce Arabic) is adapted from the Project Dulce, an American Diabetes Association (ADA)-recognized Diabetes Self-Management Education Support (DSMES) program. Project Dulce Arabic comprises both peer-led diabetes education in Arabic and a 3-month text messaging program (Dulce Digital). The main aim of the study is to examine the effectiveness of a more culturally and linguistically appropriate diabetes education program in improving diabetes knowledge, beliefs, and self-management as well as hemoglobin A1C.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Are a participant of Metro Caring

• Self-identified Arab

• Diagnosed with type 2 diabetes mellitus (T2DM)

• HbA1c ≥7.5% in the last 30 days

• Able to speak, read, write, and comprehend in English and Arabic

• Have access to a cell phone that can receive/send text messages throughout the study

Locations
United States
California
San Ysidro Health
COMPLETED
El Cajon
Colorado
Metro Caring
RECRUITING
Denver
Contact Information
Primary
Ahmed Khattab, MD
akhattab@scripps.edu
8586782129
Backup
Lannea Hand, MS, RDN
LHand@metrocaring.org
720-860-7200
Time Frame
Start Date: 2023-02-17
Estimated Completion Date: 2026-06-30
Participants
Target number of participants: 48
Treatments
Other: Project Dulce + Dulce Digital
Participants will participate in a peer-led group diabetes self-management education and support program and receive ongoing support via text messages designed to improve knowledge, health beliefs, self-management behaviors and clinical outcomes.
Related Therapeutic Areas
Sponsors
Collaborators: National Center for Advancing Translational Sciences (NCATS)
Leads: Scripps Whittier Diabetes Institute

This content was sourced from clinicaltrials.gov